Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Cediranib & Olaparib Comp To Bevacizu in Pts w/ Recur Glioblas Who Have Not Rcvd Prior VEGF Thrpy

Protocol: OSU-17330

Full Title

A Randomized Phase II Trial of Cediranib and Olaparib Compared To Bevacizumab in Patients with Recurrent Glioblastoma Who Have Not Received Prior VEGF Therapy

Brain Cancer Gliomas